IL-4 receptors on human medulloblastoma tumours serve as a sensitive target for a circular permuted IL-4-Pseudomonas exotoxin fusion protein

British Journal of Cancer

Volumn 86, Issue 2, 2002, Pages 285-291

  Joshi, B H ^a   Leland, P ^a   Silber, J ^c   Kreitman, R J ^b   Pastan, I ^b   Berger, M ^d   Puri, R K ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

IL 4 receptor; Immunofluorescence; Medulloblastoma; Subunit composition

Indexed keywords

CELL PROTEIN; CELL RECEPTOR; CYTOTOXIN; HYBRID PROTEIN; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; IODINE 125; MESSENGER RNA; PSEUDOMONAS EXOTOXIN; RECEPTOR SUBTYPE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG SENSITIVITY; DRUG TARGETING; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE; MEDULLOBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADP RIBOSE TRANSFERASES; BACTERIAL TOXINS; BRAIN NEOPLASMS; EXOTOXINS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOCONJUGATES; MEDULLOBLASTOMA; RECEPTORS, INTERLEUKIN-4; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; VIRULENCE FACTORS;

EID: 0037148426     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600034     Document Type: Article

References (33)

1. Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor
2. Complete regression of established human glioblastoma tumor xenograft by interleukin-4 toxin therapy
3. Interleukin-4 receptor expression on AIDS- associated Kaposi's Sarcoma cells and their targeting by a chimeric protein comprised of circularly permutaed Interleukin-4 and Pseudomonas exotoxin
4. Interleukin-4 receptor-directed cytotoxin therapy of AIDS-associated Kaposi's sarcoma tumors in xenograft model
5. Interleukin-13 receptor alpha chain: A novel tumor-associated transmembrane protein in primary explants of human malignant gliomas
6. In situ expression of Interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures
7. Structure, function, and targeting of interleukin 4 receptors on human head and neck cancer cells
8. Establishment and characterization of four human medulloblastoma-derived cell lines
9. A circularly permutated recombinant interleukin 4 toxin with increased activity
10. Circularly permuted interleukin 4 retains proliferative and binding activity
11. Increased antitumor activity of a circularly permuted interleukin 4-toxin in mice with interleukin 4 receptor-bearing human carcinoma
12. Suramin blocks binding of interieukin-4 to its receptors on human tumor cells and interleukin-4-induced mitogenic response
13. Human breast carcinoma cells express type II IL-4 receptors and are sensitive to antitumour activity of a chimeric IL-4-Pseudomonas exotoxin fusion protein in vitro and in vivo
14. In vivo expression of the interleukin 4 receptor alpha by astrocytes in epilepsy cerebral cortex
15. Receptors for interleukin (IL)-4 do not associate with the common gamma chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells
16. Structure of IL-13 receptor: Analysis of subunit composition in cancer and immune cells
17. Human ovarian-carcinoma cell lines express IL-4 and IL-13 receptors: Comparison between IL-4- and IL-13-induced signal transduction
18. Structure of and signal transduction through interleukin-4 and interleukin-13 receptors
19. Interleukin-13 receptor alpha′ but not alpha chain: A functional component of interleukin-4 receptors
20. Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4
21. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumour cell growth in vitro by interleukin-4
22. The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor
23. Conversion of interleukin-13 into a high affinity agonist by a single amino acid substitution
24. Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL4-Pseudomonas exotoxin chimeric protein
25. Structure and function of interleukin-4 and its receptor
26. Preclinical devdopment of a recombinant toxin containing circularly permuted interleukin 4 and truncated Pseudomonas exotoxin for therapy of malignant astrocytoma
27. An improved circularly permuted interleukin 4-toxin is highly cytotoxic to human renal cell carcinoma cells. Introduction of gamma c chain in RCC cells does not improve sensitivity
28. Expression of high-affinity interleukin 4 receptors on murine sarcoma cells and receptor-mediated cytotoxicity of tumor cells to chimeric protein between interleukin 4 and Pseudomonas exotoxin
29. Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma
30. Descriptive epidemiology of primary central nervous system tumours in children: A population-based study
31. Inhibition of colon and breast carcinoma cell growth by interleukin-4
32. Interleukin 4 inhibits growth of a human lung tumor cell line in vitro and has therapeutic activity against xenografts of this cell line in vivo